|
Click here to see: Part 2 - Human immunoglobulin proteins (in the PDB code order)
Updates from 09/05/2001 are available in
IMGT/3Dstructure-DB.
IMGT/3Dstructure-DB entries (cards) are identified by the
PDB code.
Click on a PDB code to get the corresponding IMGT/3Dstructure-DB card.
Protein Name |
PDB Code |
Fragment (1) | Ligands | Experimental Technique | Resolution | PDB Release Date | References |
---|---|---|---|---|---|---|---|
17B |
1g9m |
Fab
|
HIV-1 gp120 (envelope protein)/CD4 |
X-ray diffraction |
2.20 |
27-dec-00 |
28 |
17B |
1g9n |
Fab
|
HIV-1 gp120 (envelope protein)/CD4 |
X-ray diffraction |
2.90 |
27-dec-00 |
42 |
17B |
1gc1 |
Fab
|
HIV-1 gp120 (envelope protein)/CD4 |
X-ray diffraction |
2.50 |
19-aug-98 |
28 |
3D6 |
1dfb |
Fab
|
|
X-ray diffraction |
2.70 |
31-oct-93 |
10 |
3D6 |
1obe |
Fab
|
HIV-1 gp41 synthetic peptide |
theoretical model |
|
15-may-97 |
17 |
9E |
1dx3 |
Fv
|
|
theoretical model |
|
15-dec-00 |
38 |
B7-15A2 |
1aqk |
Fab
|
|
X-ray diffraction |
1.84 |
04-feb-98 |
26 |
Bre |
1b0w |
VL
|
|
X-ray diffraction |
1.80 |
22-dec-99 |
31 |
Bre |
1bre |
VL
|
|
X-ray diffraction |
2.00 |
15-oct-95 |
16 |
Bre |
1qp1 |
(VL)3
|
|
X-ray diffraction |
2.06 |
28-jun-99 |
37 |
Cle |
1lil |
L2
|
|
X-ray diffraction |
2.65 |
15-may-97 |
20 |
Fab-12 |
1cz8 |
Fab
|
Vascular endothelial growth factor |
X-ray diffraction |
2.40 |
20-mar-00 |
33 |
HULYS11 |
1bvk |
Fv
|
Lysozyme [hen egg white] |
X-ray diffraction |
2.70 |
16-feb-99 |
27 |
HULYS11 |
1bvl |
Fv
|
|
X-ray diffraction |
2.87 |
16-feb-99 |
22 |
Hil |
8fab |
Fab
|
|
X-ray diffraction |
1.80 |
31-oct-93 |
8 |
IgE Cepsilon2 |
1g84 |
CH2
|
|
NMR, 15 structures |
|
16-may-01 |
48 |
IgG1 |
1fc1 |
Fc
|
|
X-ray diffraction |
2.90 |
15-jul-92 |
3 |
IgG1 |
1fc2 |
Fc
|
Fragment B of protein A [Staphylococcus aureus] |
X-ray diffraction |
2.80 |
15-jul-92 |
3 |
IgG1 |
1iis |
Fc
|
Fc gamma III low affinity receptor |
X-ray diffraction |
3.00 |
09-may-01 |
49 |
IgG1 |
1iix |
Fc
|
Fc gamma III low affinity receptor |
X-ray diffraction |
3.50 |
09-may-01 |
49 |
Iga1 |
1iga |
IgA
|
|
theoretical model; scattering fitting |
|
15-jun-99 |
32 |
Ige Epsilon-1 |
1fp5 |
Fc
|
|
X-ray diffraction |
2.30 |
27-sep-00 |
46 |
IgmRf2A2 |
1dee |
Fab
|
|
X-ray diffraction |
2.70 |
14-jun-00 |
41 |
Jto |
1cd0 |
(VL)2
|
|
X-ray diffraction |
1.90 |
06-mar-00 |
36 |
Kau Cold Agglutinin |
1qlr |
Fab
|
|
X-ray diffraction |
2.83 |
14-sep-00 |
50 |
Kol |
2fb4 |
Fab
|
|
X-ray diffraction |
1.90 |
12-jul-89 |
6 |
Kol |
2ig2 |
Fab
|
|
X-ray diffraction |
3.00 |
12-jul-89 |
6 |
Len (mutant) |
3lve |
VL
|
|
X-ray diffraction |
2.00 |
18-may-99 |
30 |
Len (mutant) |
4lve |
(VL)2
|
|
X-ray diffraction |
2.30 |
18-may-99 |
29 |
Len |
1lve |
VL
|
|
X-ray diffraction |
1.95 |
21-jan-98 |
23 |
Len |
2lve |
VL
|
|
X-ray diffraction |
2.70 |
18-may-99 |
29 |
Len |
5lve |
VL
|
|
X-ray diffraction |
2.00 |
18-feb-00 |
30 |
Loc |
1bjm |
L2
|
|
X-ray diffraction |
2.20 |
07-dec-95 |
19 |
Loc |
3bjl |
L2
|
|
X-ray diffraction |
2.30 |
07-dec-95 |
19 |
Loc |
4bjl |
L2
|
|
X-ray diffraction |
2.40 |
07-dec-95 |
19 |
Loi |
2loi |
(VL)2
|
|
theoretical model |
|
29-dec-99 |
35 |
M3C65 |
1dl7 |
Fv
|
|
X-ray diffraction |
2.35 |
13-dec-00 |
39 |
M4L/Y(27D)D/Q89D/T94H Mutant Of Len |
1eeu |
(VL)2
|
|
X-ray diffraction |
1.60 |
03-feb-01 |
51 |
M4L/Y(27D)D/T94H Mutant Of Len |
1eeq |
(VL)2
|
|
X-ray diffraction |
1.50 |
01-feb-01 |
51 |
Mak33 |
1fh5 |
Fab
|
|
X-ray diffraction |
2.90 |
13-sep-00 |
47 |
Mcg-Weir Hybrid |
1mcw |
L2
|
|
X-ray diffraction |
3.50 |
15-oct-90 |
7 |
Mcg |
1a8j |
L2
|
Aspartame |
X-ray diffraction |
2.70 |
17-jun-98 |
25 |
Mcg |
1dcl |
L2
|
|
X-ray diffraction |
2.30 |
15-may-97 |
5 |
Mcg |
1mcb |
L2
|
N-Acetyl-L-Gln-D-Phe-L-His-D-Pro-OH |
X-ray diffraction |
2.70 |
31-jan-94 |
13 |
Mcg |
1mcc |
L2
|
N-Acetyl-L-Gln-D-Phe-L-His-D-Pro-NH2 |
X-ray diffraction |
2.70 |
31-jan-94 |
13 |
Mcg |
1mcd |
L2
|
N-Acetyl-D-Phe-B-Ala-L-His-D-Pro-NH2 |
X-ray diffraction |
2.70 |
31-jan-94 |
12 |
Mcg |
1mce |
L2
|
N-Acetyl-L-Gln-D-Phe-L-His-D-Pro-B-Ala-OH |
X-ray diffraction |
2.70 |
31-jan-94 |
13 |
Mcg |
1mcf |
L2
|
N-Acetyl-L-Gln-D-Phe-L-His-D-Pro-B-Ala-B-Ala-OH |
X-ray diffraction |
2.70 |
31-jan-94 |
12 |
Mcg |
1mch |
L2
|
N-Acetyl-L-Gln-D-Phe-L-His-D-Pro-B-Ala-B-Ala-OH |
X-ray diffraction |
2.70 |
31-jan-94 |
13 |
Mcg |
1mci |
L2
|
N-Acetyl-D-Phe-L-His-D-Pro-OH |
X-ray diffraction |
2.70 |
31-jan-94 |
13 |
Mcg |
1mcj |
L2
|
N-Acetyl-D-Phe-L-His-D-Pro-NH2 |
X-ray diffraction |
2.70 |
31-jan-94 |
13 |
Mcg |
1mck |
L2
|
N-Acetyl-D-Glu-L-His-D-Pro-NH2 |
X-ray diffraction |
2.70 |
31-jan-94 |
13 |
Mcg |
1mcl |
L2
|
N-Acetyl-D-His-L-Pro-OH |
X-ray diffraction |
2.70 |
31-jan-94 |
13 |
Mcg |
1mcn |
L2
|
N-Acetyl-D-His-L-Pro-NH2 |
X-ray diffraction |
2.70 |
31-jan-94 |
13 |
Mcg |
1mco |
Ig with a hinge deletion
|
|
X-ray diffraction |
3.20 |
31-jan-94 |
14 |
Mcg |
1mcq |
L2
|
N-Acetyl-L-His-D-Pro-NH2 |
X-ray diffraction |
2.70 |
31-jan-94 |
13 |
Mcg |
1mcr |
L2
|
N-Acetyl-L-His-D-Pro-OH |
X-ray diffraction |
2.70 |
31-jan-94 |
13 |
Mcg |
1mcs |
L2
|
N-Acetyl-L-Gln-D-Phe-L-His-D-Pro-OH |
X-ray diffraction |
2.70 |
31-jan-94 |
13 |
Mcg |
2mcg |
L2
|
|
X-ray diffraction |
2.00 |
15-jul-92 |
2 |
Mcg |
3mcg |
L2
|
|
X-ray diffraction |
2.00 |
15-oct-90 |
5 |
Mez |
1dql |
Fv
|
|
X-ray diffraction |
2.60 |
04-oct-00 |
44 |
Newm (2) |
7fab |
Fab
|
|
X-ray diffraction |
2.00 |
31-jan-94 |
11 |
Pot |
1igm |
Fv
|
|
X-ray diffraction |
2.30 |
31-oct-93 |
9 |
Q38D Mutant Of Len |
1efq |
VL
|
|
X-ray diffraction |
1.60 |
09-feb-01 |
51 |
Rec |
1ek3 |
(VL)2
|
|
X-ray diffraction |
1.90 |
06-mar-01 |
51 |
Rei |
1ar2 |
VL
|
|
X-ray diffraction |
2.80 |
12-nov-97 |
24 |
Rei |
1rei |
(VL)2
|
|
X-ray diffraction |
2.00 |
17-feb-84 |
1 |
Reiv-T39K |
1bww |
VL
|
|
X-ray diffraction |
1.70 |
29-dec-99 |
24 |
Rf-An |
1adq |
Fab
|
Autoantigen IgG Fc |
X-ray diffraction |
3.15 |
16-sep-98 |
21 |
Rhe |
2rhe |
VL
|
|
X-ray diffraction |
1.60 |
09-oct-88 |
4 |
Tr1.9 |
1vge |
Fab
|
|
X-ray diffraction, single crystal |
2.00 |
10-jun-96 |
18 |
Undefined |
1e4k |
Fc
|
Fc gamma III low affinity receptor (CD16) |
X-ray diffraction |
3.20 |
06-aug-00 |
45 |
Undefined |
1f6a |
Fc
|
Fc epsilon RI alpha (high-affinity receptor) |
X-ray diffraction |
3.50 |
20-jul-00 |
40 |
Undefined |
1hou |
Fv
|
|
theoretical model |
|
23-dec-99 |
34 |
Undefined |
1qac |
(VL)2
|
|
X-ray diffraction |
1.80 |
23-feb-00 |
43 |
Wat |
1wtl |
(VL)2
|
|
X-ray diffraction |
1.90 |
01-nov-94 |
15 |
Wil |
2cd0 |
(VL)2
|
|
X-ray diffraction |
1.80 |
08-mar-00 |
36 |
(1) Fragment legend :
(2) Click here for "Particularities in protein designations: Human immunoglobulins: New and Newm "
Created: 26/06/2001
VH Ig heavy V-DOMAIN. VL Ig light V-DOMAIN. Fab Fragment antigen-binding. Complete light chain (Ig light V-DOMAIN and C-DOMAIN) disulfide-linked with an Ig heavy V-DOMAIN and CH1 C-DOMAIN. Fv Ig heavy V-DOMAIN (VH) non covalently linked with an Ig light V-DOMAIN (VL). Fc Fragment crystallizable. Two identical disulfide-linked Ig heavy CH2 and CH3 C-DOMAINs. (VL)n n Ig light V-DOMAINs non covalently linked. L2 Dimer of two non covalently linked complete light chains. IgA Complete Immunoglobulin A. scFv Two Ig (or by extension T cell receptor)
V-DOMAINs covalently linked. CH2 Ig heavy CH2 C-DOMAIN.
Last updated: Wednesday, 12-Jun-2024 16:02:20 CEST
Author: Manuel Ruiz